Employing ATP as a New Adjuvant Promotes the Induction of Robust Antitumor Cellular Immunity by a PLGA Nanoparticle Vaccine

ACS Applied Materials & Interfaces
Qishu ZhangYanbing Ma

Abstract

Tumor vaccines based on synthetic human papillomavirus (HPV) oncoprotein E7 and/or E6 peptides have shown encouraging results in preclinical model studies and human clinical trials. However, the clinical efficacy may be limited by the disadvantages of vulnerability to enzymatic degradation and low immunogenicity of peptides. To further improve the potency of vaccine, we developed a poly(lactide-co-glycolide)-acid (PLGA) nanoparticle, which encapsulated the antigenic peptide HPV16 E744-62, and used adenosine triphosphate (ATP), one of the most important intracellular metabolites and an endogenous extracellular danger signal for the immune system, as a new adjuvant component. The results showed that PLGA nanoparticles increased the in vivo stability, lymph node accumulation, and dendritic cell (DC) uptake of the E7 peptide; in addition, ATP further increased the migration, nanoparticle uptake, and maturation of DCs. Preventive immunization with ATP-adjuvanted nanoparticles completely abolished the growth of TC-1 tumors in mice and produced long-lasting immunity against tumor rechallenge. When tumors were fully established, therapeutic immunization with ATP-adjuvanted nanoparticles still significantly inhibited tumor progression. ...Continue Reading

References

Mar 22, 2006·Proceedings of the National Academy of Sciences of the United States of America·Julie A Champion, Samir Mitragotri
Jan 4, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Gemma G KenterCornelis J M Melief
Jun 7, 2008·Nature Medicine·Victor AppayDavid A Price
Nov 6, 2009·The New England Journal of Medicine·Gemma G KenterCornelis J M Melief
Jan 21, 2010·Cancer Research·Laetitia AymericLaurence Zitvogel
Feb 23, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Fabienne DanhierVéronique Préat
Mar 21, 2012·Nature Immunology·Laurence ZitvogelGuido Kroemer
Jul 4, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sara TrabanelliRoberto M Lemoli
Dec 5, 2013·Human Vaccines & Immunotherapeutics·Fazren AzmiIstvan Toth
May 16, 2014·Nature·Marco IdzkoHolger K Eltzschig
Aug 5, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Christian WischkeAndreas Lendlein
May 17, 2015·Autonomic Neuroscience : Basic & Clinical·Francesco Di Virgilio, Marta Vuerich
Sep 10, 2015·Proceedings of the National Academy of Sciences of the United States of America·Todd BartkowiakMichael A Curran
Oct 30, 2015·Human Vaccines & Immunotherapeutics·Mojgan Allahyari, Elham Mohit
Nov 1, 2016·Nature Reviews. Immunology·Lorenzo GalluzziGuido Kroemer
Nov 16, 2016·Free Radical Biology & Medicine·Manoranjan ArakhaSuman Jha
Mar 10, 2017·ACS Nano·Guizhi ZhuXiaoyuan Chen
Dec 27, 2017·Papillomavirus Research·Aleyo ChabedaInga I Hitzeroth

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.